ApiFix signs Canadian distribution agreement and completes first No. American cases

Editor’s note: In a related story, Jessica Robb, 14, will be the 146th person in the world to have the ApiFix implant. She will undergo surgery in October. 

Joint Solutions Alliance Corporation

ApiFix signed an exclusive distribution agreement with Canada’s Joint Solutions Alliance Corporation.

The Company completes first cases in North America

Medical device company ApiFix announced it signed an exclusive distribution agreement with Joint Solutions Alliance Corporation (JSA), a national Canadian medical device and services distribution organization. JSA’s primary focus is finding medical devices that allows surgeons to preserve motion, movement, and function where previously the only solution for the patient was fusion.

Following the agreement, Ron El-Hawary, M.D., Chief of Orthopedics at the IWK Health Centre in Halifax, Canada, performed two ApiFix implant surgeries. Randal Betz, M.D., former president of the Scoliosis Research Society (SRS), observed the operation.

ApiFix ratchet system for scoliosis treatment

The ratchet-based system developed by ApiFix captures incremental changes.

ApiFix has invented and developed a non-fusion spinal implant system for the correction of Adolescent Idiopathic Scoliosis (AIS). The implant system is inserted in a minimally invasive surgical procedure. The ApiFix system aims to improve the quality of life of patients who undergo scoliosis surgery, save hospitalization and OR time, and substantially reduce costs and recovery time associated with standard scoliosis surgery. In contrast to standard scoliosis surgery, the ApiFix system represents a game-changer in the market, with a spinal implant system, inserted in a short procedure, followed by a brief recovery period, and maintains spine flexibility.

“With our vast experience in the spine surgical field, we instantly understood the significance of the device for scoliosis patients and its market potential. We are delighted to join forces with ApiFix and exclusively distribute their products in Canada,” stated Joint Solution Alliance President Alan Tanner.

ApiFix CEO Eran Feldhay, M.D., remarked: “We are excited to begin our penetration in the North American markets with Canadian patients. We are convinced that together with JSA we’ll succeed in delivering the ApiFix solution to more patients around the world.”

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize